Skip to main content
Erschienen in: Quality of Life Research 7/2013

01.09.2013

Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases

verfasst von: Luciana Scalone, Roberta Ciampichini, Stefano Fagiuoli, Ivan Gardini, Francesco Fusco, Laura Gaeta, Anna Del Prete, Giancarlo Cesana, Lorenzo G. Mantovani

Erschienen in: Quality of Life Research | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess the performance of the EQ-5D-5L version compared with the standard EQ-5D-3L in a clinical setting targeted at patients with chronic hepatic diseases (CHDs).

Methods

We introduced the 5L descriptive system into a cost-of-illness study involving patients with different CHDs. The patients completed a questionnaire including the two versions of the EQ-5D, together with other questions related to their condition. We tested the feasibility, the level of inconsistency, the redistribution properties among consistent responses, the ceiling effect, the discriminative power, and the convergent validity of the 5L compared with the 3L system.

Results

A total of 1,088 valid patients were recruited: 62 % male, 19–89 (median = 59) years old. Patients had chronic hepatitis from HCV (31.8 %) or HBV infections (29.3 %) or other causes (7.8 %), 20.4 % had cirrhosis, 11.9 % underwent liver transplantation, and 7.8 % had hepatic carcinoma. Less than 1 % of EQ-5D-5L were returned blank, and 1.6 % or less of missing values were calculated on the dimensions of the partially completed questionnaires. The proportion and weight of inconsistent responses (i.e., 3L responses that were at least two levels away from the 5L responses) was 2.9 % and 1.2 on average, respectively. Regarding redistribution, 57–65 % of the patients answering level 2 with the 3L version redistributed their responses to levels 2 or 4 with the 5L version. A relative 7 % reduction of the ceiling effect was found. Furthermore, the absolute informativity increased but the relative informativity slightly decreased in every domain, and the convergent validity with the VAS improved.

Conclusions

In a clinical setting involving CHD patients, the EQ-5D-5L was shown to be feasible and with promising levels of performance. Our findings suggest that the 5L performs better in at least some of the properties analyzed, and encourage further research to also test other psychometric properties of this new version of the EQ-5D.
Literatur
1.
Zurück zum Zitat Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33, 337–343.PubMedCrossRef Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33, 337–343.PubMedCrossRef
2.
Zurück zum Zitat Ong, S. C., Mak, B., Aung, M. O., Li, S. C., & Lim, S. G. (2008). Health-related quality of life in chronic hepatitis B patients. Hepatology, 47(4), 1108–1117.PubMedCrossRef Ong, S. C., Mak, B., Aung, M. O., Li, S. C., & Lim, S. G. (2008). Health-related quality of life in chronic hepatitis B patients. Hepatology, 47(4), 1108–1117.PubMedCrossRef
3.
Zurück zum Zitat McLernon, D. J., Dillon, J., & Donnan, P. T. (2008). Health-state utilities in liver disease: A systematic review. Medical Decision Making, 28(4), 582–592.PubMedCrossRef McLernon, D. J., Dillon, J., & Donnan, P. T. (2008). Health-state utilities in liver disease: A systematic review. Medical Decision Making, 28(4), 582–592.PubMedCrossRef
4.
Zurück zum Zitat Russel, R. T., Feurer, I. D., Wisawatapnimit, P., & Pinson, C. W. (2009). The validity of the EQ-5D US preference weights in liver transplant candidates and recipients. Liver Transplantation, 15(1), 88–95.CrossRef Russel, R. T., Feurer, I. D., Wisawatapnimit, P., & Pinson, C. W. (2009). The validity of the EQ-5D US preference weights in liver transplant candidates and recipients. Liver Transplantation, 15(1), 88–95.CrossRef
5.
Zurück zum Zitat Bjornsson, E., Verbaan, H., Oksanen, A., Fryden, A., Johansson, J., Friberg, S., et al. (2009). Health-related quality of life in patients with different stages of liver disease induced by hepatitis C. Scandinavian Journal of Gastroenterology, 44(7), 878–887.PubMedCrossRef Bjornsson, E., Verbaan, H., Oksanen, A., Fryden, A., Johansson, J., Friberg, S., et al. (2009). Health-related quality of life in patients with different stages of liver disease induced by hepatitis C. Scandinavian Journal of Gastroenterology, 44(7), 878–887.PubMedCrossRef
6.
Zurück zum Zitat Pickard, A. S., De Leon, M. C., Kohlmann, T., Cella, D., & Rosenbloom, S. (2007). Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Medical Care, 45(3), 259–263.PubMedCrossRef Pickard, A. S., De Leon, M. C., Kohlmann, T., Cella, D., & Rosenbloom, S. (2007). Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Medical Care, 45(3), 259–263.PubMedCrossRef
7.
Zurück zum Zitat Pickard, A. S., Kohlmann, T., Janssen, M. F., Bonsel, G., Rosenbloom, S., & Cella, D. (2007). Evaluating equivalency between response systems. Application of the Rasch model to a 3-level and 5-level EQ-5D. Medical Care, 45(9), 812–819.PubMedCrossRef Pickard, A. S., Kohlmann, T., Janssen, M. F., Bonsel, G., Rosenbloom, S., & Cella, D. (2007). Evaluating equivalency between response systems. Application of the Rasch model to a 3-level and 5-level EQ-5D. Medical Care, 45(9), 812–819.PubMedCrossRef
8.
Zurück zum Zitat Janssen, M. F., Birnie, E., Haagsma, J. A., & Bonsel, G. J. (2008). Comparing the standard EQ-5D three-level system with a five-level version. Value in Health, 11(2), 275–284.PubMedCrossRef Janssen, M. F., Birnie, E., Haagsma, J. A., & Bonsel, G. J. (2008). Comparing the standard EQ-5D three-level system with a five-level version. Value in Health, 11(2), 275–284.PubMedCrossRef
9.
Zurück zum Zitat Janssen, M. F., Birnie, E., & Bonsel, G. J. (2008). Quantification of the level descriptors for the standard EQ-5D three-level system and five-level version according to two methods. Quality of Life Research, 15, 463–473.CrossRef Janssen, M. F., Birnie, E., & Bonsel, G. J. (2008). Quantification of the level descriptors for the standard EQ-5D three-level system and five-level version according to two methods. Quality of Life Research, 15, 463–473.CrossRef
10.
Zurück zum Zitat Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1736.PubMedCrossRef Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1736.PubMedCrossRef
11.
Zurück zum Zitat Kim, S. H., Kim, H. J., Lee, S. I., Jo, M. W. (2011). Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Quality of Life Research published online 23 September 2011. Kim, S. H., Kim, H. J., Lee, S. I., Jo, M. W. (2011). Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Quality of Life Research published online 23 September 2011.
12.
Zurück zum Zitat Ciampichini, R., Scalone, L., Gardini, I., Gaeta, L., Del Prete, A., Fusco, F., et al. (2011). Comparison of health-related quality of life between hepatitis, cirrhosis, liver transplantation and hepatic carcinoma: results of the COME study. Value in Health, 14(PGI30), 174. Ciampichini, R., Scalone, L., Gardini, I., Gaeta, L., Del Prete, A., Fusco, F., et al. (2011). Comparison of health-related quality of life between hepatitis, cirrhosis, liver transplantation and hepatic carcinoma: results of the COME study. Value in Health, 14(PGI30), 174.
13.
Zurück zum Zitat Fusco, F., Scalone, L., Ciampichini, R., Fagioli, S., Gardini, I., Gaeta, L., et al. (2011). Comparison of treatment and indirect costs between hepatitis, cirrhosis, liver transplantation and hepatic carcinoma: Results of the COME study. Value In Health, 14(PGI16), 171. Fusco, F., Scalone, L., Ciampichini, R., Fagioli, S., Gardini, I., Gaeta, L., et al. (2011). Comparison of treatment and indirect costs between hepatitis, cirrhosis, liver transplantation and hepatic carcinoma: Results of the COME study. Value In Health, 14(PGI16), 171.
14.
Zurück zum Zitat World Medical Association (WMA) Declaration of Helsinki. Adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964, amended by the 29th World Medical Assembly, Tokyo, Japan, October 1975, the 35th World Medical Assembly, Venice, Italy, October 1983, and the 41st World Medical Assembly, Hong Kong, September 1989. World Medical Association (WMA) Declaration of Helsinki. Adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964, amended by the 29th World Medical Assembly, Tokyo, Japan, October 1975, the 35th World Medical Assembly, Venice, Italy, October 1983, and the 41st World Medical Assembly, Hong Kong, September 1989.
15.
Zurück zum Zitat Herdman, M., Fox-Rushby, J., Rabin, R., Badia, X., & Selai, C. (2003). Producing other language versions of the EQ-5D. In R. Brooks, R. Rabin, & F. de Charro (Eds.), The measurement and valuation of health status using EQ-5D: A European perspective. Dordrecht: Kluwer Academic Publishers. Herdman, M., Fox-Rushby, J., Rabin, R., Badia, X., & Selai, C. (2003). Producing other language versions of the EQ-5D. In R. Brooks, R. Rabin, & F. de Charro (Eds.), The measurement and valuation of health status using EQ-5D: A European perspective. Dordrecht: Kluwer Academic Publishers.
16.
Zurück zum Zitat Badia, X., Montserrat, R., Herdman, M., & Kind, P. (2001). A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Medical Decision Making, 21, 7–16.PubMedCrossRef Badia, X., Montserrat, R., Herdman, M., & Kind, P. (2001). A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Medical Decision Making, 21, 7–16.PubMedCrossRef
17.
Zurück zum Zitat van Hout, B., Janssen, M. F., Feng, Y., Kohlmann, T., Busschbach, J., Golicki, D., et al. (2012). Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health, 15(5), 708–715.PubMedCrossRef van Hout, B., Janssen, M. F., Feng, Y., Kohlmann, T., Busschbach, J., Golicki, D., et al. (2012). Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health, 15(5), 708–715.PubMedCrossRef
18.
Zurück zum Zitat Bas Janssen, M. F., Birnie, E., & Bonsel, G. J. (2007). Evaluating the discriminatory power of EQ-5D, HUI2 and HUI3 in a US general population survey using Shannon’s indices. Quality of Life Research, 16(5), 895–904.PubMedCrossRef Bas Janssen, M. F., Birnie, E., & Bonsel, G. J. (2007). Evaluating the discriminatory power of EQ-5D, HUI2 and HUI3 in a US general population survey using Shannon’s indices. Quality of Life Research, 16(5), 895–904.PubMedCrossRef
19.
Zurück zum Zitat Polinder, S., Haagsma, J. A., Bonsel, G., et al. (2010). The measurement of long-term health-related quality of life after injury: Comparison of EQ-5D and the health utilities index. Injury Prevention, 16(3), 147–153.PubMedCrossRef Polinder, S., Haagsma, J. A., Bonsel, G., et al. (2010). The measurement of long-term health-related quality of life after injury: Comparison of EQ-5D and the health utilities index. Injury Prevention, 16(3), 147–153.PubMedCrossRef
20.
Zurück zum Zitat Shannon, C. E., & Weaver, W. (1949). The mathematical theory of communication. Urbana: University of Illinois Press. Shannon, C. E., & Weaver, W. (1949). The mathematical theory of communication. Urbana: University of Illinois Press.
21.
Zurück zum Zitat Juniper, E. F., Guyatt, G. H., & Jaeshke, R. (1996). How to develop and validate a new health-related quality of life instrument. In B. Spilker (Ed.), Quality of life and pharmacoeconomics in clinical trials (pp. 49–56). Philadelphia, PA: Lippincott-Raven Publishers. Juniper, E. F., Guyatt, G. H., & Jaeshke, R. (1996). How to develop and validate a new health-related quality of life instrument. In B. Spilker (Ed.), Quality of life and pharmacoeconomics in clinical trials (pp. 49–56). Philadelphia, PA: Lippincott-Raven Publishers.
22.
Zurück zum Zitat Unal, G., de Boer, J. B., Borsboom, G. J., Brouwer, J. T., Essink-Bot, M., & de Man, R. A. (2001). A psychometric comparison of health-related quality of life measures in chronic liver disease. Journal of Clinical Epidemiology, 54(6), 587–596.PubMedCrossRef Unal, G., de Boer, J. B., Borsboom, G. J., Brouwer, J. T., Essink-Bot, M., & de Man, R. A. (2001). A psychometric comparison of health-related quality of life measures in chronic liver disease. Journal of Clinical Epidemiology, 54(6), 587–596.PubMedCrossRef
23.
Zurück zum Zitat van der Plas, S. M., Hansen, B. E., de Boer, J. B., Stijnen, T., Passchier, J., de Man, R. A., et al. (2003). Generic and disease-specific health-related quality of life in non-cirrhotic, cirrhotic and transplanted liver patients: a cross-sectional study. BMC Gastroenterology, 17(3), 33.CrossRef van der Plas, S. M., Hansen, B. E., de Boer, J. B., Stijnen, T., Passchier, J., de Man, R. A., et al. (2003). Generic and disease-specific health-related quality of life in non-cirrhotic, cirrhotic and transplanted liver patients: a cross-sectional study. BMC Gastroenterology, 17(3), 33.CrossRef
24.
Zurück zum Zitat Casanovas Taltavull, T., Jané Cabré, L., Herdman, M., Casado Collado, A., Pubill, B. P., & Fabregat Prous, J. (2007). Validation of the Spanish version of the liver disease quality of life instrument among candidates for liver transplant. Transplantation Proceedings, 39(7), 2274–2277.PubMedCrossRef Casanovas Taltavull, T., Jané Cabré, L., Herdman, M., Casado Collado, A., Pubill, B. P., & Fabregat Prous, J. (2007). Validation of the Spanish version of the liver disease quality of life instrument among candidates for liver transplant. Transplantation Proceedings, 39(7), 2274–2277.PubMedCrossRef
25.
Zurück zum Zitat Casanovas, T., Jané, L., Herdman, M., Casado, A., Garcia, B., Prat, B., et al. (2010). Assessing outcomes in liver disease patients: Reliability and validity of the Spanish version of the Liver Disease Quality of Life Questionnaire (LDQOL 1.0). Value Health, 13, 455–462.PubMedCrossRef Casanovas, T., Jané, L., Herdman, M., Casado, A., Garcia, B., Prat, B., et al. (2010). Assessing outcomes in liver disease patients: Reliability and validity of the Spanish version of the Liver Disease Quality of Life Questionnaire (LDQOL 1.0). Value Health, 13, 455–462.PubMedCrossRef
Metadaten
Titel
Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases
verfasst von
Luciana Scalone
Roberta Ciampichini
Stefano Fagiuoli
Ivan Gardini
Francesco Fusco
Laura Gaeta
Anna Del Prete
Giancarlo Cesana
Lorenzo G. Mantovani
Publikationsdatum
01.09.2013
Verlag
Springer Netherlands
Erschienen in
Quality of Life Research / Ausgabe 7/2013
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-012-0318-0

Weitere Artikel der Ausgabe 7/2013

Quality of Life Research 7/2013 Zur Ausgabe